4//SEC Filing
STAIANO EDWARD 4
Accession 0001209191-05-034298
CIK 0001009405other
Filed
Jun 30, 8:00 PM ET
Accepted
Jul 1, 8:25 AM ET
Size
14.3 KB
Accession
0001209191-05-034298
Insider Transaction Report
Form 4
STAIANO EDWARD
Director
Transactions
- Disposition to Issuer
BCII Common Stock
2005-07-01$33.00/sh−68,000$2,244,000→ 0 total - Disposition to Issuer
BCII Stock Option Plan
2005-07-01$16.55/sh−28,000$463,400→ 0 totalExercise: $16.45Exp: 2011-12-21→ BCII Common Stock (28,000 underlying) - Disposition to Issuer
BCII Stock Option Plan
2005-07-01$26.75/sh−10,000$267,500→ 0 totalExercise: $6.25Exp: 2013-01-31→ BCII Common Stock (10,000 underlying) - Disposition to Issuer
BCII Stock Option Plan
2005-07-01$24.10/sh−20,000$482,000→ 0 totalExercise: $24.10Exp: 2014-11-23→ BCII Common Stock (20,000 underlying)
Footnotes (2)
- [F1]Disposed of pursuant to agreement and plan of merger between issuer and Genzyme Corporation and Macbeth Corporation in exchange for a cash payment of $33.00 per share of BCII Common Stock.
- [F2]Each BCII Stock Option became exercisable in full upon consummation of the merger and was cancelled in the merger and was cancelled in the merger in exchange for a cash payment per share subject to the option equal to the difference between the exercise price of the option and $33.00.
Documents
Issuer
BONE CARE INTERNATIONAL INC
CIK 0001009405
Entity typeother
Related Parties
1- filerCIK 0001202765
Filing Metadata
- Form type
- 4
- Filed
- Jun 30, 8:00 PM ET
- Accepted
- Jul 1, 8:25 AM ET
- Size
- 14.3 KB